BEST IN CLASS FOR INTERNATIONAL REGULATORY COMPLIANCE

CONSULTING, AUDITING AND TRAINING THROUGHOUT THE PRODUCT LIFECYCLE

NSF International works with in vitro diagnostic companies of all sizes, providing customized end-to-end services throughout the product lifecycle.

NEW IVD APP!

NSF has launched a brand new IVD app to help companies prepare for IVD regulation (EU) 2017/746. Looking to get the latest IVD industry news and regulatory updates straight to your device? Look no further! Available to download today for free on Apple’s App Store and Android’s Google Play.

Our IVD Services

From concept through to distribution, our expert services enable:

  • Efficient clinical trial conduct
  • Risk appropriate regulatory compliance
  • Implementation of effective and lean quality management systems
  • Maximized contributions of existing staff
  • The highest levels of product quality and safety
  • Improved competitive advantage and speed to market

Our diverse team allows us to combine global regulatory knowledge with industry best practices to provide you with customized technical, quality, compliance and regulatory services.

For more information about the services we offer to the medical device industry visit our website or contact us.

Go to article: Home | Breaking down sound barriersGo to article: In This IssueGo to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: ContentsGo to article: NSFGo to article: NewsGo to article: Coronavirus Executive BriefingGo to article: confinis Company Insight Go to article: confinisGo to article: Patients reluctant to visit hospitals due to Covid-19Go to article: Sandvik Company InsightGo to article: Sandvik Go to article: Medtronic wins CE mark for Evolut TAVR system in low-risk patientsGo to article: Smiths InterconnectGo to article: Timeline for resuming elective surgeries becoming more clear amid the Covid-19 pandemicGo to article: Covid-19 accelerates remote patient monitoring device market growthGo to article: Ventilators market to reach $5.2B during Covid-19 pandemicGo to article: Repsol Company Insight Go to article: Repsol Go to article: The medical industry briefingGo to article: KUK ElectronicGo to article: The respirator race: how manufacturers are repurposing for Covid-19Go to article: MARACA International Company InsightGo to article: Maraca InternationalGo to article: Covid-19: the med tech bottlenecksGo to article: LemoGo to article: Catch your breath: a device that spots critical Covid-19 casesGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Enter the voicebot: an unlikely solution to the elderly care crisis?Go to article: BioiniciaGo to article: ‘Healthable’ hearing aids: empowering young people with hearing lossGo to article: XmrealityGo to article: Smart glasses in surgery: expert analysis outside the operating roomGo to article: STSGo to article: Perspectum Diagnostics: the biggest start-up you’ve never heard ofGo to article: FargoGo to article: Ready player one: the marriage of video games and medical technologyGo to article: ICF MercantileGo to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2 ) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: Deals in brief powered by GlobalDataGo to article: The key list powered by GlobalDataGo to article: EventsGo to article: Next Issue